合成路线1
该中间体在本合成路线中的序号:
(III) The reaction of p-chlorobenzoic acid (I) with SOCl2 gives p-chlorobenzoyl chloride (II), which is esterified with 4-fluorophenol (III) affording 4-fluorophenyl-4-chlorobenzoate (IV). The isomerization of (IV) with AlCl3 yields 4-chloro-2'-hydroxy-5'-fluorobenzophenone (V), which is condensed with 4-aminobutyric acid (VI) by means of sodium methoxide in ethanol giving 4-[[alpha-(p-chlorophenyl)-5-fluoro-2-hydroxybenzylidene]amino]butyric acid (VII). The reaction of (VII) with SOCl2 in THF affords the corresponding acyl chloride (VIII), which is then treated with NH3. An alternative way of converting the acid (VII) into its amide is by treatment with carbonyldiimidazole (A) and liquid NH3 in THF.
【1】
Kaplan, J.P.; et al.; Derives alpha-phenyl-benzylideniques des acides amines. FR 2358887 .
|
【2】
Kaplan, J.P.; et al. (Sanofi-Synthelabo); Benzylidene derivatives. ES 450300; FR 2319338; GB 1506808; JP 52019644; US 4094992 .
|
【3】
Kaplan, J.P.; et al. (Sanofi-Synthelabo); Preparation of benzylidene derivatives. DE 2830034; ES 471606; FR 2397397; GB 2001066; JP 54019953 .
|
【4】
Serradell, M.N.; Owen, R.T.; Blancafort, P.; Castaner, J.; Progabide. Drugs Fut 1980, 5, 9, 445.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11353 |
1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole)
|
530-62-1 |
C7H6N4O |
详情 | 详情
|
(I) |
18359 |
p-chlorobenzoic acid; 4-chlorobenzoic acid
|
74-11-3 |
C7H5ClO2 |
详情 | 详情
|
(II) |
10295 |
p-Chlorobenzoyl chloride; 4-Chlorobenzoyl chloride
|
122-01-0 |
C7H4Cl2O |
详情 | 详情
|
(III) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(IV) |
32698 |
4-Fluorophenyl 4-chlorobenzoate
|
|
C13H8ClFO2 |
详情 |
详情
|
(V) |
32699 |
(4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methanone
|
62433-26-5 |
C13H8ClFO2 |
详情 | 详情
|
(VI) |
13620 |
4-Amino-n-butyric acid; 4-Aminobutyric acid;Piperidinic acid;Piperidic acid |
56-12-2 |
C4H9NO2 |
详情 | 详情
|
(VII) |
32700 |
4-[[(Z)-(4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methylidene]amino]butyric acid
|
|
C17H15ClFNO3 |
详情 |
详情
|
(VIII) |
32701 |
4-[[(Z)-(4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methylidene]amino]butanoyl chloride
|
|
C17H14Cl2FNO2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The title compound has been obtained by condensation of methanesulfonate (I) with 4-fluorophenol (II) by means of NaNH2 in DMF.
【1】
Gallardo Carrera, A. (Fordonal SL); Process for the preparation of 4-aminopiperidine derivs.. ES 8601133 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49579 |
3-[(3S,4R)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidinyl]propyl methanesulfonate
|
|
C18H28ClN3O6S |
详情 |
详情
|
(II) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) The condensation of 2-iodophenylacetic (I) with 4-fluorophenol (II) by means of K2CO3 in nitrobenzene al 160 C gives 2-(4-fluoophenoxy)phenylacetic acid (III), which by treatment with refluxing SOCl2 is converted to the corresponding acid chloride (IV). The cyclization of (IV) by means of AlCl3 in refluxing dichloroethane affords 2-fluoro-10,11-dihydro-11-oxodibenzo[b,f]oxepin (V), which is treated with 2-(dimethylamino)ethylthiol (VI) and boron trifluoride ethereate in acetic acid yielding 2-fluoro-11-[2-(dimethylamino)ethythio]dibenzo[b,f]oxepin (VII). The reaction of (VII) with phenyl chloro-formate (VIII) by means of K2CO3 in methylene chloride affords 2-fluoro-11-[2-(N-methyl-N-phenyloxycarbonylamino)ethythio]dibenzo[b,f]oxepin (IX), which is finally hydrolyzed with KOH-ethylene glycol al 155 C.
【1】
Morales-Alanis, H.; et al.; Antiandrogenic activity of a series of des-A-steroid derivatives. J Med Chem 1985, 28, 12, 1796.
|
【2】
Anderson, V.B.; Ong, H.H.; Profitt, J.A. (Aventis SA); Aminoalkylthiobenzoxepines, process for their preparation as well as pharmaceutical compsns. containing them. JP 7995583 .
|
【3】
Castaner, J.; Prous, J.; Fluradoline hydrochloride. Drugs Fut 1985, 10, 10, 813.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27337 |
2-(2-iodophenyl)acetic acid
|
18698-96-9 |
C8H7IO2 |
详情 | 详情
|
(II) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(III) |
27338 |
2-[2-(4-fluorophenoxy)phenyl]acetic acid
|
|
C14H11FO3 |
详情 |
详情
|
(IV) |
27339 |
2-[2-(4-fluorophenoxy)phenyl]acetyl chloride
|
|
C14H10ClFO2 |
详情 |
详情
|
(V) |
27340 |
8-fluorodibenzo[b,f]oxepin-10(11H)-one
|
|
C14H9FO2 |
详情 |
详情
|
(VI) |
27341 |
2-(dimethylamino)ethylhydrosulfide
|
13242-44-9 |
C4H11NS |
详情 | 详情
|
(VII) |
27342 |
N-[2-[(8-fluorodibenzo[b,f]oxepin-10-yl)sulfanyl]ethyl]-N,N-dimethylamine
|
|
C18H18FNOS |
详情 |
详情
|
(VIII) |
13580 |
1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate
|
1885-14-9 |
C7H5ClO2 |
详情 | 详情
|
(IX) |
27343 |
phenyl 2-[(8-fluorodibenzo[b,f]oxepin-10-yl)sulfanyl]ethyl(methyl)carbamate
|
|
C24H20FNO3S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) 1) The cyclization of 4-fluorophenol (I) with chronic acid (II) by means of polyphosphonic acid (PPA) at 120 C gives 6-fluoro-2-methyl-chroman-4-one (III), which is then condensed with KCN and ammonium carbonate in hot acetamide.
【1】
Ueda, K.; Nomura, K.; Tanaka, S.; Nakai, N. (Eisai Co., Ltd.); Hydantoin derivatives, processes for preparing them and pharmaceutical compositions containing them. EP 0193855; JP 61197581 .
|
【2】
Ueda, K.; et al. (Eisai Co., Ltd.); Treating complications of diabetes mellitus with hydantoin derivatives. BE 889698; DE 3128606; FR 2487353; GB 2080304; JP 57045185; US 4780472; US 4874869 .
|
【3】
Prous, J.; Castaner, J.; METHOSORBINIL. Drugs Fut 1989, 14, 4, 325.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
20599 |
(E)-2-butenoic acid; crotonic acid |
3724-65-0 |
C4H6O2 |
详情 | 详情
|
(III) |
20600 |
6-fluoro-2-methyl-2,3-dihydro-4H-chromen-4-one
|
88754-96-5 |
C10H9FO2 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) 2) The condensation of 4-fluorophenol (I) with ethyl (S)-lactate (II) by means of diethyl azodicarboxylate and triphenylphosphine in THF gives ethyl 2(R)-(4-fluorophenoxy)propionate (III), which is reduced with LiAlH4 in THF yielding 2(R)-(4-fluorophenoxy)propanol (IV). The reaction of (IV) with Br2 and triphenylphosphine in DMF affords 1-bromo-2(R)-(4-fluorophenoxy)propane (V), which is condensed with N-benzoyl-2-hydroxyglycine (VI) by means of methanesulfonic acid to give (RS)-N-benzoyl-2-[2-(1-bromo-2(R)propoxy)-5-fluorophenyl]glycine (VII). The cyclization of (VII) by means of acetic anhydride and K2CO3 in acetone yields 6-fluoro-2(R)-methyl-2'-phenylspiro[2,3-dihydro-4H-1-benzopyran-4(RS),4'-oxazolidin]-5'-one (VIII), which is hydrolyzed with refluxing formic acid-HCl affording 4(RS)-amino-6-fluoro-2(R)-methyl-2,3-dihydro-4H-1-benzopyran-4-carboxylic acid (IX). The esterification of (IX) with Cl2SO and methanol gives the corresponding methyl ester (X), which is submitted to optical resolution with alpha-chymotrypsine to yield methyl 4(S)-amino-6-fluoro-2(R)-methyl-2,3-dihydro-4H-1-benzopyran-4-carboxylate (XI). Finally, this compound is cyclized with sodium cyanate in acetic acid.
【1】
Prous, J.; Castaner, J.; METHOSORBINIL. Drugs Fut 1989, 14, 4, 325.
|
【2】
Moore, B.S.; Urban, F.J.; Dirlam, N.L.; Novel synthesis of the aldose reductase inhibitor sorbinil via amidoalkylation, intramolecular oxazolidin-5-one alkylation, and chymotrypsin resolution. J Org Chem 1987, 52, 16, 3587.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
16659 |
ethyl (2S)-2-hydroxypropanoate; (S)-ethyl lactate
|
687-47-8 |
C5H10O3 |
详情 | 详情
|
(III) |
20603 |
ethyl (2R)-2-(4-fluorophenoxy)propanoate
|
|
C11H13FO3 |
详情 |
详情
|
(IV) |
20604 |
(2R)-2-(4-fluorophenoxy)-1-propanol
|
|
C9H11FO2 |
详情 |
详情
|
(V) |
20605 |
1-[[(1R)-2-bromo-1-methylethyl]oxy]-4-fluorobenzene; (1R)-2-bromo-1-methylethyl 4-fluorophenyl ether
|
|
C9H10BrFO |
详情 |
详情
|
(VI) |
20606 |
2-(benzoylamino)-2-hydroxyacetic acid
|
16555-77-4 |
C9H9NO4 |
详情 | 详情
|
(VII) |
20607 |
2-(benzoylamino)-2-(2-[[(1R)-2-bromo-1-methylethyl]oxy]-5-fluorophenyl)acetic acid
|
|
C18H17BrFNO4 |
详情 |
详情
|
(VIII) |
20608 |
6-Fluoro-2(R)-methyl-2'-phenyl-3,4,4',5'-tetrahydro-2H-spiro[1-benzopyran-4,4'-oxazol]-5'-one
|
|
C18H14FNO3 |
详情 |
详情
|
(IX) |
20609 |
(2R)-4-amino-6-fluoro-2-methyl-3,4-dihydro-2H-chromene-4-carboxylic acid
|
|
C11H12FNO3 |
详情 |
详情
|
(X) |
20610 |
methyl (2R)-4-amino-6-fluoro-2-methyl-3,4-dihydro-2H-chromene-4-carboxylate
|
|
C12H14FNO3 |
详情 |
详情
|
(XI) |
20611 |
(2R,4S)-4-amino-6-fluoro-2-methyl-3,4-dihydro-2H-chromene-4-carboxylic acid
|
|
C11H12FNO3 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) The chiral amine intermediate (XV) has been obtained as follows: The alkylation of 4-fluorophenol (I) with allyl bromide (II) and K2CO3 gives the allyl ether (III), which by thermal rearrangement at 210 C yields 2-allyl-4-fluorophenol (IV). The silylation of (IV) with TBDMS-Cl and imidazole affords the silyl ether (V), which is submitted to hydroboration with BH3 and H2O2 to provide the propanol (VI). The oxidation of (VI) with Dess Martin periodinane (DMP) gives the aldehyde (VII), which is condensed with the phosphorane (VIII) to yield the pentenoic ester (IX). The reduction of (IX) with DIBAL affords the unsaturated alcohol, which is desilylated with TBAF in THF furnishing the diol (XI). The treatment of (XI) under the Sharpless asymmetric epoxidation conditions ((-)-DET and titanium tetraisopropoxide) gives, after cyclization with NaOH, 1(R)-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2(S)-yl)-1,2-ethanediol (XII), which is selectively tosylated with TsCl and pyridine yielding the monotosylate (XIII). The reaction of (XIII) with sodium azide in DMF affords the azide (XIV), which is reduced to the corresponding amine (XV) with H2 over Pd/C in ethanol.
【1】
Chandrasekhar, S.; Reddy, M.V.; Enantioselective total synthesis of the antihypertensive agent (S,R,R,R)-nebivolol. Tetrahedron 2000, 56, 34, 6339.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
40848 |
1-(allyloxy)-4-fluorobenzene; allyl 4-fluorophenyl ether
|
|
C9H9FO |
详情 |
详情
|
(IV) |
40849 |
2-allyl-4-fluorophenol
|
|
C9H9FO |
详情 |
详情
|
(V) |
40850 |
(2-allyl-4-fluorophenoxy)(tert-butyl)dimethylsilane; 2-allyl-4-fluorophenyl tert-butyl(dimethyl)silyl ether
|
|
C15H23FOSi |
详情 |
详情
|
(VI) |
40851 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-1-propanol
|
|
C15H25FO2Si |
详情 |
详情
|
(VII) |
40852 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)propanal
|
|
C15H23FO2Si |
详情 |
详情
|
(VIII) |
14182 |
ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane
|
1099-45-2 |
C22H21O2P |
详情 | 详情
|
(IX) |
40853 |
ethyl (E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-pentenoate
|
|
C19H29FO3Si |
详情 |
详情
|
(X) |
40854 |
(E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-penten-1-ol
|
|
C17H27FO2Si |
详情 |
详情
|
(XI) |
40855 |
4-fluoro-2-[(E)-5-hydroxy-3-pentenyl]phenol
|
|
C11H13FO2 |
详情 |
详情
|
(XII) |
40856 |
(1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1,2-ethanediol
|
|
C11H13FO3 |
详情 |
详情
|
(XIII) |
40857 |
(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(XIV) |
40858 |
(1R)-2-azido-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H12FN3O2 |
详情 |
详情
|
(XV) |
40859 |
(1R)-2-amino-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H14FNO2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) Ether (III) was prepared by condensation of (S)-4-(hydroxymethyl)butyrolactone (I) and 4-fluorophenol (II) in the presence of diisopropylazodicarboxylate (DIAD) and triphenylphosphine under Mitsunobu conditions. Then, reduction of lactone (III) with DIBAL-H in toluene at -78 C gave lactol (IV), which was converted to silyl ether (V) by treatment with tert-butyldimethylsilyl chloride (TBDMS-Cl) and imidazole. Subsequent reaction of (V) with TBDMS-Br in CH2Cl2 at -78 C, followed by condensation with the lithium acetylide derived from acetylene (VI), yielded compound (VII) as a mixture of isomers. Chromatographic separation of the mixture provided the desired trans isomer, which was deprotected by treatment with tetra-n-butylammonium fluoride to give alcohol (VIII). This was then condensed with N,O-bis(phenoxycarbonyl)hydroxylamine (IX) in the presence of DIAD and Ph3P to furnish the hydroxamic acid derivative (X). Finally, concomitant deprotection of the O-phenoxycarbonyl group and substitution of the remaining phenoxy group for an amino group by treatment with methanolic ammonia in a pressure tube, provided the title compound.
【1】
Cai, X.; Grewal, G.; Hussoin, S.; Fura, A.; Scannell, R.; Biftu, T.; Qian, C. (CytoMed, Inc.); Cpds. and methods for the treatment of cardiovascular, inflammatory and immune disorders. JP 1998506096; US 5703093; US 5792776; WO 9600212 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46090 |
(5R)-5-(hydroxymethyl)dihydro-2(3H)-furanone
|
|
C5H8O3 |
详情 |
详情
|
(II) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(III) |
19640 |
(5S)-5-[(4-fluorophenoxy)methyl]dihydro-2(3H)-furanone
|
175212-40-5 |
C11H11FO3 |
详情 | 详情
|
(IV) |
19641 |
(5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanol
|
|
C11H13FO3 |
详情 |
详情
|
(V) |
19642 |
tert-butyl(dimethyl)silyl (5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl ether; tert-butyl([(5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]oxy)dimethylsilane
|
|
C17H27FO3Si |
详情 |
详情
|
(VI) |
19643 |
tert-butyl(dimethyl)silyl 3-butynyl ether; tert-butyl(3-butynyloxy)dimethylsilane
|
|
C10H20OSi |
详情 |
详情
|
(VII) |
19644 |
tert-butyl(dimethyl)silyl 4-[(5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]-3-butynyl ether; tert-butyl[(4-[(5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]-3-butynyl)oxy]dimethylsilane
|
|
C21H31FO3Si |
详情 |
详情
|
(VIII) |
19645 |
4-[(2S,5S)-5-[(4-fluorophenoxy)methyl]tetrahydro-2-furanyl]-3-butyn-1-ol
|
|
C15H17FO3 |
详情 |
详情
|
(IX) |
19646 |
1-[([[(phenoxycarbonyl)oxy]amino]carbonyl)oxy]benzene
|
|
C14H11NO5 |
详情 |
详情
|
(X) |
19647 |
(2S,5S)-2-[(4-fluorophenoxy)methyl]-5-(4-[(phenoxycarbonyl)[(phenoxycarbonyl)oxy]amino]-1-butynyl)tetrahydrofuran
|
|
C29H26FNO7 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The reaction of 4-fluorophenol (I) with epichlorohydrin (II) by means of K2CO3 in refluxing acetone gives 2-(4-fluorophenoxymethyl)oxirane (III), which is submitted to an enantioselective ring opening with the Jacobsen (R,R)-catalyst yielding a mixture of the (R)-diol (IV) and unaltered epoxide (V), easily separated by column chromatography. The reaction of (IV) with tosyl chloride and pyridine in dichloromethane affords the primary monotosylate (VI), which is converted into the chiral epoxide (VII) by reaction with NaH in THF/DMF. The reaction of (VII) with allylmagnesium bromide (VIII) in ethyl ether gives the 2-hexenol derivative (IX), which is treated with benzenesulfonyl chloride and DMAP yielding the sulfonate (X). The ozonolysis of (X) with ozone in dichloromethane affords the aldehyde (XI), which is condensed with ethoxycarbonylmethylene(triphenyl)phosphorane (XII) yielding the 2-heptenoic ester (XIII). The reduction of (XIII) with diisobutylaluminum hydride (DIBAL) in toluene/dichloromethane provides the 2-hepten-1-ol (XIV), which is epoxidized with cumene hydroperoxide in the presence of diisopropyl (+)-tartrate and Ti(Oi-Pr)4 in dichloromethane to give the chiral epoxyalcohol (XV). The reaction of (XV) with triphenylphosphine/CCl4 in chloroform affords the corresponding chloride (XVI).
【1】
Adhikari, S.S.; Hymavathi, L.; Sadalapure, K.; Sharma, G.V.M.; Sreenivas, P.; Mhaskar, S.V.; Lalitha, S.V.S.; Chorghade, M.S.; Murugaiah, A.M.S.; Prasad, T.R.; Reddy, B.S.; Gurjar, M.K.; Reddy, V.G.; Krishna, P.R. (LeukoSite, Inc.); Substd. oxygen alicyclic cpds., including methods for synthesis thereof. WO 0001381 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14713 |
benzenesulfonyl chloride
|
98-09-9 |
C6H5ClO2S |
详情 | 详情
|
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(III) |
22150 |
2-[(4-fluorophenoxy)methyl]oxirane; 4-fluorophenyl 2-oxiranylmethyl ether
|
18123-82-5 |
C9H9FO2 |
详情 | 详情
|
(IV) |
32985 |
(2R)-3-(4-fluorophenoxy)-1,2-propanediol
|
|
C9H11FO3 |
详情 |
详情
|
(V) |
32986 |
4-fluorophenyl (2S)oxiranylmethyl ether; (2S)-2-[(4-fluorophenoxy)methyl]oxirane
|
108648-25-5 |
C9H9FO2 |
详情 | 详情
|
(VI) |
32987 |
(2S)-3-(4-fluorophenoxy)-2-hydroxypropyl 4-methylbenzenesulfonate
|
|
C16H17FO5S |
详情 |
详情
|
(VII) |
22150 |
2-[(4-fluorophenoxy)methyl]oxirane; 4-fluorophenyl 2-oxiranylmethyl ether
|
18123-82-5 |
C9H9FO2 |
详情 | 详情
|
(VIII) |
10386 |
Allyl(bromo)magnesium
|
1730-25-2 |
C3H5BrMg |
详情 | 详情
|
(IX) |
32988 |
(2R)-1-(4-fluorophenoxy)-5-hexen-2-ol
|
|
C12H15FO2 |
详情 |
详情
|
(X) |
32989 |
(1R)-1-[(4-fluorophenoxy)methyl]-4-pentenyl benzenesulfonate
|
|
C18H19FO4S |
详情 |
详情
|
(XI) |
32990 |
(1R)-1-[(4-fluorophenoxy)methyl]-4-oxobutyl benzenesulfonate
|
|
C17H17FO5S |
详情 |
详情
|
(XII) |
14182 |
ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane
|
1099-45-2 |
C22H21O2P |
详情 | 详情
|
(XIII) |
32991 |
ethyl (E,6R)-7-(4-fluorophenoxy)-6-[(phenylsulfonyl)oxy]-2-heptenoate
|
|
C21H23FO6S |
详情 |
详情
|
(XIV) |
32992 |
(1R,4E)-1-[(4-fluorophenoxy)methyl]-6-hydroxy-4-hexenyl benzenesulfonate
|
|
C19H21FO5S |
详情 |
详情
|
(XV) |
32993 |
(1R)-1-[(4-fluorophenoxy)methyl]-3-[(2R,3S)-3-(hydroxymethyl)oxiranyl]propyl benzenesulfonate
|
|
C19H21FO6S |
详情 |
详情
|
(XVI) |
32994 |
(1R)-3-[(2R,3R)-3-(chloromethyl)oxiranyl]-1-[(4-fluorophenoxy)methyl]propyl benzenesulfonate
|
|
C19H20ClFO5S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) Condensation of 4-fluorophenol (I) with 4-fluorobenzaldehyde (II) by heating with K2CO3 in N,N-dimethylacetamide provides 4-(4-fluorophenoxy)benzaldehyde (III), which is finally converted into the target product by reaction with semicarbazide hydrochloride (IV) and NaOAc in the refluxing mixture EtOH/H2O.
【1】
Lam, G.N.; Ramu, K.; Chien, B.; Development of a high-performance liquid chromatographic-tandem mass spectrometric method for the determination of pharmacokinetics of Co 102862 in mouse, rat, monkey and dog plasma. J Chromatogr B - Biomed Appl 2000, 749, 1, 1. |
【2】
Quail, J.W.; Dimmock, J.R.; Puthucode, R.N.; Pugazhenthi, U.; Stables, J.P.; Anticonvulsant activity of various aryl, aryldine and aryloxyaryl semicarbazones. Eur J Med Chem 1998, 33, 7-8, 595.
|
【3】
Dimmock, J.R.; Puthucode, R.N. (University of Saskatchewan); Semicarbazones having CNS activity and pharmaceutical preparations containing same. EP 0836591; JP 1999506109; US 5741818; WO 9640628 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(III) |
22233 |
4-(4-fluorophenoxy)benzaldehyde
|
|
C13H9FO2 |
详情 |
详情
|
(IV) |
23944 |
1-Hydrazinecarboxamide
|
563-41-7 |
CH5N3O |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) Condensation of 4-bromobenzaldehyde (I) with 4-fluorophenol (II) in the presence of K2CO3 in refluxing dimethylacetamide gave ether (III). Subsequent reductive amination of (III) with cycloheptylamine (IV) using ethanolic NaBH4 afforded secondary amine (V). Phenyl carbamate (VIII) was obtained by treatment of aminopyridine (VI) with phenyl chloroformate (VII) and dimethylaniline. Condensation of this carbamate with amine (V) in the presence of Et3N in refluxing toluene furnished urea (IX) (1). Both sulfide groups of (IX) were finally oxidized to sulfone using meta-chloroperbenzoic acid in CH2Cl2.
【1】
Tanaka, A.; Terasawa, T.; Hagihara, H.; Ishibe, N.; Sawada, M.; Sakuma, Y.; Hashimoto, M.; Takasugi, H.; Tanaka, H.; Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 3. Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas with weak toxicological effects on adrenal glands. J Med Chem 1998, 41, 22, 4408. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22231 |
4-Bromobenzaldehyde
|
1122-91-4 |
C7H5BrO |
详情 | 详情
|
(II) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(III) |
22233 |
4-(4-fluorophenoxy)benzaldehyde
|
|
C13H9FO2 |
详情 |
详情
|
(IV) |
22234 |
cycloheptanamine; cycloheptylamine
|
5452-35-7 |
C7H15N |
详情 | 详情
|
(VI) |
22235 |
N-cycloheptyl-N-[4-(4-fluorophenoxy)benzyl]amine; N-[4-(4-fluorophenoxy)benzyl]cycloheptanamine
|
|
C20H24FNO |
详情 |
详情
|
(VI) |
22239 |
6-methyl-2,4-bis(methylsulfanyl)-3-pyridinylamine; 6-methyl-2,4-bis(methylsulfanyl)-3-pyridinamine
|
|
C8H12N2S2 |
详情 |
详情
|
(VII) |
13580 |
1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate
|
1885-14-9 |
C7H5ClO2 |
详情 | 详情
|
(VIII) |
18000 |
phenyl 6-methyl-2,4-bis(methylsulfanyl)-3-pyridinylcarbamate
|
|
C15H16N2O2S2 |
详情 |
详情
|
(IX) |
22241 |
N-cycloheptyl-N-[4-(4-fluorophenoxy)benzyl]-N'-[6-methyl-2,4-bis(methylsulfanyl)-3-pyridinyl]urea
|
|
C29H34FN3O2S2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) Condensation of 4-bromobenzaldehyde (I) with 4-fluorophenol (II) in the presence of K2CO3 in refluxing dimethylacetamide gave ether (III). Subsequent reductive amination of (III) with cycloheptylamine (IV) using ethanolic NaBH4 afforded secondary amine (V). Phenyl carbamate (VIII) was obtained by treatment of aminopyridine (VI) with phenyl chloroformate (VII) and dimethylaniline. Finally, condensation of this carbamate with amine (V) in the presence of Et3N in DMF at 100 C furnished the target urea.
【1】
Frank, A.; Karn, H.; Spanig, H. (Abbott GmbH & Co. KG); Production of 1-hydroxyalkyl-5-nitroimidazoles. DE 2359625; FR 2253019; GB 1481349 .
|
【2】
Frank, A.; Dockner, T.; Karn, H. (Abbott GmbH & Co. KG); Process for the preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole of high purity. EP 0150407 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22231 |
4-Bromobenzaldehyde
|
1122-91-4 |
C7H5BrO |
详情 | 详情
|
(II) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(III) |
22233 |
4-(4-fluorophenoxy)benzaldehyde
|
|
C13H9FO2 |
详情 |
详情
|
(IV) |
22234 |
cycloheptanamine; cycloheptylamine
|
5452-35-7 |
C7H15N |
详情 | 详情
|
(V) |
22235 |
N-cycloheptyl-N-[4-(4-fluorophenoxy)benzyl]amine; N-[4-(4-fluorophenoxy)benzyl]cycloheptanamine
|
|
C20H24FNO |
详情 |
详情
|
(VI) |
22236 |
2,4,6-trimethyl-3-pyridinylamine; 2,4,6-trimethyl-3-pyridinamine
|
|
C8H12N2 |
详情 |
详情
|
(VII) |
13580 |
1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate
|
1885-14-9 |
C7H5ClO2 |
详情 | 详情
|
(VIII) |
22238 |
phenyl 2,4,6-trimethyl-3-pyridinylcarbamate
|
|
C15H16N2O2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(IX) 2,5-Bis(p-bromophenyl)furan (II) was prepared by cyclodehydration of diketone (I) in refluxing acetic anhydride. Displacement of both bromine atoms by copper(I) cyanide in boiling quinoline generated the dicyano derivative (V). Alternatively, furan (V) was prepared by addition of p-cyanobenzaldehyde (III) to divinyl sulfone (IV) in the presence of a thiazolium catalyst. After conversion of the cyano groups of (V) into bis-imidate (VI), reaccion with ethanolic ammonia furnished amidine (VII). The stable symmetrical carbonate (X) was obtained by reaction of p-fluorophenyl chloroformate (VIII) with p-fluorophenol (IX) in the presence of pyridine. Finally, reaction of the bis(amidine) compound (VII) with carbonate (X) yielded the title compound.
【1】
Kawada, A.; Aragane, Y.; Maeda, A.; Tezuka, T.; Heterocycl Commun 1996, 2, 2, 135-140.
|
【2】
Das, B.P.; Boykin, D.W.; Synthesis and antiprotozoal activity of 2,5-bis (4-guanylphenyl) furans. J Med Chem 1977, 20, 4, 531-536.
|
【3】
Rahmathullah, S.M.; et al.; Prodrugs for amidines: Synthesis and anti-Pneumocystis carinii activity of carbamates of 2,5-bis(4-amidinophenyl)furan. J Med Chem 1999, 42, 19, 3994.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35811 |
1,4-bis(4-bromophenyl)-1,4-butanedione
|
|
C16H12Br2O2 |
详情 |
详情
|
(II) |
35812 |
2,5-bis(4-bromophenyl)furan
|
|
C16H10Br2O |
详情 |
详情
|
(III) |
17552 |
4-formylbenzonitrile; 4-Cyanobenzaldehyde
|
105-07-7 |
C8H5NO |
详情 | 详情
|
(IV) |
35813 |
divinyl sulfone; dioxo(divinyl)-lambda(6)-sulfane
|
77-77-0 |
C4H6O2S |
详情 | 详情
|
(V) |
35814 |
4-[5-(4-cyanophenyl)-2-furyl]benzonitrile
|
|
C18H10N2O |
详情 |
详情
|
(VI) |
35815 |
ethyl 4-(5-[4-[ethoxy(imino)methyl]phenyl]-2-furyl)benzenecarboximidoate
|
|
C22H22N2O3 |
详情 |
详情
|
(VII) |
35816 |
4-(5-[4-[amino(imino)methyl]phenyl]-2-furyl)benzenecarboximidamide
|
|
C18H16N4O |
详情 |
详情
|
(VIII) |
35817 |
1-[(chlorocarbonyl)oxy]-4-fluorobenzene
|
38377-38-7 |
C7H4ClFO2 |
详情 | 详情
|
(IX) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(X) |
35818 |
bis(4-fluorophenyl) carbonate
|
|
C13H8F2O3 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(I)
【1】
余婧,张稳稳,李映红,等.2008.奈必洛尔的不对称合成.有机化学,28(3):511~514 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
40848 |
1-(allyloxy)-4-fluorobenzene; allyl 4-fluorophenyl ether
|
|
C9H9FO |
详情 |
详情
|
(III) |
40849 |
2-allyl-4-fluorophenol
|
|
C9H9FO |
详情 |
详情
|
(IV) |
40850 |
(2-allyl-4-fluorophenoxy)(tert-butyl)dimethylsilane; 2-allyl-4-fluorophenyl tert-butyl(dimethyl)silyl ether
|
|
C15H23FOSi |
详情 |
详情
|
(V) |
40851 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-1-propanol
|
|
C15H25FO2Si |
详情 |
详情
|
(VI) |
40852 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)propanal
|
|
C15H23FO2Si |
详情 |
详情
|
(VII) |
40853 |
ethyl (E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-pentenoate
|
|
C19H29FO3Si |
详情 |
详情
|
(VIII) |
40854 |
(E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-penten-1-ol
|
|
C17H27FO2Si |
详情 |
详情
|
(IX) |
40855 |
4-fluoro-2-[(E)-5-hydroxy-3-pentenyl]phenol
|
|
C11H13FO2 |
详情 |
详情
|
(X) |
40856 |
(1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1,2-ethanediol
|
|
C11H13FO3 |
详情 |
详情
|
(XI) |
40857 |
(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(XII) |
40858 |
(1R)-2-azido-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H12FN3O2 |
详情 |
详情
|
(XIII) |
40859 |
(1R)-2-amino-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H14FNO2 |
详情 |
详情
|
(XIV) |
67297 |
(1S)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1,2-ethanediol |
|
C11H13FO3 |
详情 | 详情
|
(XV) |
67298 |
(S)-2-((S)-6-fluorochroman-2-yl)-2-hydroxyethyl benzoate |
|
C18H17FO4 |
详情 | 详情
|
(XVI) |
67299 |
(S)-2-((S)-6-fluorochroman-2-yl)-2-(tosyloxy)ethyl benzoate |
|
C25H23FO6S |
详情 | 详情
|
(XVII) |
67300 |
(R)-6-fluoro-2-((R)-oxiran-2-yl)chroman |
|
C11H11FO2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(IV)
【1】
王乃兴,于安广,王桂霞,等。2007.(R,R,R,S)2,2'-[亚氨基二(亚甲基)]双-(6-氟-3,4-二氢-2H-1-苯骈吡喃-2-甲醇)奈比洛尔盐酸盐的合成方法。发明专利申请公开说明书,1978442. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
67319 |
(2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexaol |
50-70-4 |
C6H14O6 |
详情 | 详情
|
(II) |
45944 |
(1S,2S)-1,2-bis[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-1,2-ethanediol
|
1707-77-3 |
C12H22O6 |
详情 | 详情
|
(III) |
36759 |
(4R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde
|
15186-48-8 |
C6H10O3 |
详情 | 详情
|
(IV) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(V) |
60391 |
1-(5-fluoro-2-hydroxyphenyl)-1-ethanone
|
394-32-1 |
C8H7FO2 |
详情 | 详情
|
(VI) |
67320 |
(S)-2-(R-2,2-dimethyl-1,3-dioxolan-4-yl)-6-fluorochroman-4-one |
|
C14H15FO4 |
详情 | 详情
|
(VII) |
67314 |
(S)-1-((S)-6-fluorochroman-2-yl)ethane-1,2-diol |
|
C11H13FO3 |
详情 | 详情
|
(VIII) |
40857 |
(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(IX) |
67305 |
(S)-2-amino-1-((S)-6-fluorochroman-2-yl)ethanol |
|
C11H14FNO2 |
详情 | 详情
|
(XI) |
67321 |
(R)-2-(R-2,2-dimethyl-1,3-dioxolan-4-yl)-6-fluorochroman-4-one |
|
C14H15FO4 |
详情 | 详情
|
(XII) |
67313 |
(S)-1-((R)-6-fluorochroman-2-yl)ethane-1,2-diol |
|
C11H13FO3 |
详情 | 详情
|
(XIII) |
67315 |
(S)-2-((R)-6-fluorochroman-2-yl)-2-hydroxyethyl 4-methylbenzenesulfonate |
|
C18H19FO5S |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(I)
【1】
陈鹏,吕春雷。2005.DL-奈比洛尔及盐酸盐的制备方法。发明专利申请公开说明书,1683355. |
【2】
Chandrasekhar S,Reddy MV.2000.Enantioselective total synthesis of the antihypertensive agent (S,R,R,R)-nebivolol. Tetrahedron, 56: 6339~6344. |
【3】
Charles W,Johannes MS, Visser GS, et al. 1998. Zr-catalyzed kinetic resolution of allylic ethers and mo-catalyzed chromene formation in synthesis. Enantioselective total synthesis of the antihypertensive agent (S,R,R,R)-nebivolol. J Am Chem Soc,120: 8340~8347. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
40855 |
4-fluoro-2-[(E)-5-hydroxy-3-pentenyl]phenol
|
|
C11H13FO2 |
详情 |
详情
|
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
40848 |
1-(allyloxy)-4-fluorobenzene; allyl 4-fluorophenyl ether
|
|
C9H9FO |
详情 |
详情
|
(III) |
40849 |
2-allyl-4-fluorophenol
|
|
C9H9FO |
详情 |
详情
|
(IV) |
40850 |
(2-allyl-4-fluorophenoxy)(tert-butyl)dimethylsilane; 2-allyl-4-fluorophenyl tert-butyl(dimethyl)silyl ether
|
|
C15H23FOSi |
详情 |
详情
|
(V) |
40851 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-1-propanol
|
|
C15H25FO2Si |
详情 |
详情
|
(VI) |
40852 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)propanal
|
|
C15H23FO2Si |
详情 |
详情
|
(VII) |
40853 |
ethyl (E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-pentenoate
|
|
C19H29FO3Si |
详情 |
详情
|
(VIII) |
40854 |
(E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-penten-1-ol
|
|
C17H27FO2Si |
详情 |
详情
|
(X) |
40856 |
(1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1,2-ethanediol
|
|
C11H13FO3 |
详情 |
详情
|
(XI) |
40857 |
(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(XII) |
40858 |
(1R)-2-azido-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H12FN3O2 |
详情 |
详情
|
(XIII) |
40859 |
(1R)-2-amino-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H14FNO2 |
详情 |
详情
|
(XIV) |
67322 |
(1R,7S)-8-oxabicyclo[5.1.0]octane |
|
C7H12O |
详情 | 详情
|
(XV) |
67323 |
tert-butyl(((1S,2R)-2-(4-fluoro-2-((Z)-prop-1-en-1-yl)phenoxy)cyclohept-3-en-1-yl)oxy)dimethylsilane |
|
C22H33FO2Si |
详情 | 详情
|
(XVI) |
67324 |
tert-butyl(((S)-1-((R)-6-fluoro-2H-chromen-2-yl)hex-5-en-1-yl)oxy)dimethylsilane |
|
C21H31FO2Si |
详情 | 详情
|
(XVII) |
67325 |
tert-butyl(((S)-1-((R)-6-fluoro-2H-chromen-2-yl)allyl)oxy)dimethylsilane |
|
C18H25FO2Si |
详情 | 详情
|
(XVIII) |
67326 |
(R)-2-((tert-butyldimethylsilyl)oxy)-2-((S)-6-fluorochroman-2-yl)acetaldehyde |
|
C17H25FO3Si |
详情 | 详情
|
(XIX) |
67328 |
(R)-2-(((S)-2-((tert-butyldimethylsilyl)oxy)-2-((S)-6-fluorochroman-2-yl)ethyl)amino)-1-((R)-6-fluorochroman-2-yl)ethanol |
|
C28H39F2NO4Si |
详情 | 详情
|
(XX) |
67327 |
(R)-2-(((S)-2-((tert-butyldimethylsilyl)oxy)-2-((S)-6-fluorochroman-2-yl)ethyl)amino)-1-((R)-6-fluorochroman-2-yl)ethanol hydrochloride |
|
C28H39F2NO4Si.HCl |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(I)
【1】
Trinka P, Reiter J, Beracz G, et al. 2004. New process for the preparation of racemic ([2S [2R * [R[R*]]]]) and ([2R [2S * [S[S*]]]]) -(+-)-α,α'-[imino-bis (methylene)] bis [6-fluoro-chroman-2-methanol] and its pure [2S [2R * [R[R*]]]]) -, and [2R [2S * [S[S*]]]] enantionmers. WO 2004041805. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XV) |
67337 |
(S)-2-((S)-1,2-dihydroxyethyl)-6-fluorochroman-4-one |
|
C11H11FO4 |
详情 | 详情
|
(X) |
67339 |
(R)-1-((S)-6-fluorochroman-2-yl)-2-(phenylamino)ethanol |
|
C17H18FNO2 |
详情 | 详情
|
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
67331 |
2-chloro-1-(5-fluoro-2-hydroxyphenyl)ethanone |
|
C8H6ClFO2 |
详情 | 详情
|
(III) |
67332 |
(2-(5-fluoro-2-hydroxyphenyl)-2-oxoethyl)triphenylphosphonium chloride |
|
C26H21ClFO2P |
详情 | 详情
|
(IV) |
67333 |
1-(5-fluoro-2-hydroxyphenyl)-2-(triphenylphosphoranylidene)ethanone |
|
C26H20FO2P |
详情 | 详情
|
(V) |
67334 |
(R,E)-3-(2,2-dimethyl-1,3-dioxolan-4-yl)-1-(5-fluoro-2-hydroxyphenyl)prop-2-en-1-one |
|
C14H15FO4 |
详情 | 详情
|
(VI) |
67335 |
2-(2,2-dimethyl-1,3-dioxolan-4-yl)-6-fluorochroman-4-one |
|
C14H15FO4 |
详情 | 详情
|
(VII) |
67336 |
(S)-2-((R)-1,2-dihydroxyethyl)-6-fluorochroman-4-one |
|
C11H11FO4 |
详情 | 详情
|
(VIII) |
40857 |
(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(IX) |
67338 |
(S)-6-fluoro-2-((R)-oxiran-2-yl)chroman |
|
C11H11FO2 |
详情 | 详情
|
(XI) |
40862 |
(2R)-2-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(XII) |
40863 |
(2R)-6-fluoro-2-[(2R)oxiranyl]-3,4-dihydro-2H-chromene
|
|
C11H11FO2 |
详情 |
详情
|
(XIII) |
67318 |
(S)-1-((R)-6-fluorochroman-2-yl)-2-(((S)-2-((S)-6-fluorochroman-2-yl)-2-hydroxyethyl)(phenyl)amino)ethanol |
|
C28H29F2NO4 |
详情 | 详情
|